First Subsequent Treatment After Discontinuation of Durvalumab in Unresectable, Stage III NSCLC Patients from PACIFIC


Faehling M., Planchard D., Cho B. C., Gray J. E., Paz-Ares L. G., ÖZGÜROĞLU M., ...More

ONCOLOGY RESEARCH AND TREATMENT, vol.43, pp.120, 2020 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 43
  • Publication Date: 2020
  • Journal Name: ONCOLOGY RESEARCH AND TREATMENT
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, MEDLINE
  • Page Numbers: pp.120
  • Istanbul University Affiliated: No